Literature DB >> 17245649

Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract.

Elangovan Gopal1, Seiji Miyauchi, Pamela M Martin, Sudha Ananth, Penny Roon, Sylvia B Smith, Vadivel Ganapathy.   

Abstract

UNLABELLED: PURPOSE. To examine the involvement of human SMCT1, a Na+-coupled transporter for short-chain fatty acids, in the transport of nicotinate/structural analogs and monocarboxylate drugs, and to analyze its expression in mouse intestinal tract.
MATERIALS AND METHODS: We expressed human SMCT1 in X. laevis oocytes and monitored its function by [14C]nicotinate uptake and substrate-induced inward currents. SMCT1 expression in mouse intestinal tract was examined by immunofluorescence.
RESULTS: [14C]Nicotinate uptake was several-fold higher in SMCT1-expressing oocytes than in water-injected oocytes. The uptake was inhibited by short-chain/medium-chain fatty acids and various structural analogs of nicotinate. Exposure of SMCT1-expressing oocytes to nicotinate induced Na+-dependent inward currents. Measurements of nicotinate flux and associated charge transfer into oocytes suggest a Na+:nicotinate stoichiometry of 2:1. Monocarboxylate drugs benzoate, salicylate, and 5-aminosalicylate are also transported by human SMCTI. The transporter is expressed in the small intestine as well as colon, and the expression is restricted to the lumen-facing apical membrane of intestinal and colonic epithelial cells.
CONCLUSIONS: Human SMCTI transports not only nicotinate and its structural analogs but also various monocarboxylate drugs. The transporter is expressed on the luminal membrane of the epithelial cells lining the intestinal tract. SMCT1 may participate in the intestinal absorption of monocarboxylate drugs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17245649     DOI: 10.1007/s11095-006-9176-1

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  27 in total

Review 1.  Molecular features, regulation, and function of monocarboxylate transporters: implications for drug delivery.

Authors:  Bradley E Enerson; Lester R Drewes
Journal:  J Pharm Sci       Date:  2003-08       Impact factor: 3.534

Review 2.  Drug therapy for ulcerative colitis.

Authors:  Chang-Tai Xu; Shu-Yong Meng; Bo-Rong Pan
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

3.  Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids.

Authors:  Seiji Miyauchi; Elangovan Gopal; You-Jun Fei; Vadivel Ganapathy
Journal:  J Biol Chem       Date:  2004-02-13       Impact factor: 5.157

Review 4.  SLC5A8 (SMCT1)-mediated transport of butyrate forms the basis for the tumor suppressive function of the transporter.

Authors:  Naren Gupta; Pamela M Martin; Puttur D Prasad; Vadivel Ganapathy
Journal:  Life Sci       Date:  2005-12-20       Impact factor: 5.037

5.  Identity of SMCT1 (SLC5A8) as a neuron-specific Na+-coupled transporter for active uptake of L-lactate and ketone bodies in the brain.

Authors:  Pamela M Martin; Elangovan Gopal; Sudha Ananth; Lina Zhuang; Shiro Itagaki; Balakrishna M Prasad; Sylvia B Smith; Puttur D Prasad; Vadivel Ganapathy
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

6.  Expression of slc5a8 in kidney and its role in Na(+)-coupled transport of lactate.

Authors:  Elangovan Gopal; You-Jun Fei; Mitsuru Sugawara; Seiji Miyauchi; Lina Zhuang; Pamela Martin; Sylvia B Smith; Puttur D Prasad; Vadivel Ganapathy
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

7.  Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes.

Authors:  Anne-Marie Rodriguez; Barbara Perron; Ludovic Lacroix; Bernard Caillou; Gérard Leblanc; Martin Schlumberger; Jean-Michel Bidart; Thierry Pourcher
Journal:  J Clin Endocrinol Metab       Date:  2002-07       Impact factor: 5.958

8.  Human Na+ -coupled citrate transporter: primary structure, genomic organization, and transport function.

Authors:  Katsuhisa Inoue; Lina Zhuang; Vadivel Ganapathy
Journal:  Biochem Biophys Res Commun       Date:  2002-12-06       Impact factor: 3.575

9.  Human sodium-coupled citrate transporter, the orthologue of Drosophila Indy, as a novel target for lithium action.

Authors:  Katsuhisa Inoue; Lina Zhuang; Dennis M Maddox; Sylvia B Smith; Vadivel Ganapathy
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  SLC5A8, a sodium transporter, is a tumor suppressor gene silenced by methylation in human colon aberrant crypt foci and cancers.

Authors:  Hui Li; Lois Myeroff; Dominic Smiraglia; Michael F Romero; Theresa P Pretlow; Lakshmi Kasturi; James Lutterbaugh; Ronald M Rerko; Graham Casey; Jean-Pierre Issa; Joseph Willis; James K V Willson; Christoph Plass; Sanford D Markowitz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

View more
  43 in total

1.  Comparative genomics and functional analysis of the NiaP family uncover nicotinate transporters from bacteria, plants, and mammals.

Authors:  Linda Jeanguenin; Aurora Lara-Núñez; Dmitry A Rodionov; Andrei L Osterman; Nataliya Y Komarova; Doris Rentsch; Jesse F Gregory; Andrew D Hanson
Journal:  Funct Integr Genomics       Date:  2011-09-28       Impact factor: 3.410

2.  Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon.

Authors:  Sudha Ananth; Lina Zhuang; Elangovan Gopal; Shiro Itagaki; Babu Ellappan; Sylvia B Smith; Vadivel Ganapathy; Pamela Martin
Journal:  Biochem Biophys Res Commun       Date:  2010-02-21       Impact factor: 3.575

3.  Transport by SLC5A8 with subsequent inhibition of histone deacetylase 1 (HDAC1) and HDAC3 underlies the antitumor activity of 3-bromopyruvate.

Authors:  Muthusamy Thangaraju; Senthil K Karunakaran; Shiro Itagaki; Elangovan Gopal; Selvakumar Elangovan; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer       Date:  2009-10-15       Impact factor: 6.860

4.  Protein expressions and genetic variations of SLC5A8 in prostate cancer risk and aggressiveness.

Authors:  Hui-Yi Lin; Hyun Y Park; Selina Radlein; Nupam P Mahajan; Thomas A Sellers; Babu Zachariah; Julio Pow-Sang; Domenico Coppola; Vadivel Ganapathy; Jong Y Park
Journal:  Urology       Date:  2011-07-29       Impact factor: 2.649

Review 5.  Nutrient transport in the mammary gland: calcium, trace minerals and water soluble vitamins.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Christiane Albrecht; Matthias A Hediger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-02-25       Impact factor: 2.673

Review 6.  Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence.

Authors:  Luis Rajman; Karolina Chwalek; David A Sinclair
Journal:  Cell Metab       Date:  2018-03-06       Impact factor: 27.287

7.  Sodium-coupled transport of the short chain fatty acid butyrate by SLC5A8 and its relevance to colon cancer.

Authors:  Muthusamy Thangaraju; Gail Cresci; Shiro Itagaki; John Mellinger; Darren D Browning; Franklin G Berger; Puttur D Prasad; Vadivel Ganapathy
Journal:  J Gastrointest Surg       Date:  2008-07-26       Impact factor: 3.452

8.  Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling.

Authors:  Ben-Shun Hu; Shu-Ming Xiong; Gang Li; Jian-Ping Li
Journal:  Tumour Biol       Date:  2016-07-27

9.  GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon.

Authors:  Muthusamy Thangaraju; Gail A Cresci; Kebin Liu; Sudha Ananth; Jaya P Gnanaprakasam; Darren D Browning; John D Mellinger; Sylvia B Smith; Gregory J Digby; Nevin A Lambert; Puttur D Prasad; Vadivel Ganapathy
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

10.  The drug of abuse gamma-hydroxybutyrate is a substrate for sodium-coupled monocarboxylate transporter (SMCT) 1 (SLC5A8): characterization of SMCT-mediated uptake and inhibition.

Authors:  Dapeng Cui; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2009-04-23       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.